مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

337
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

243
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

COMMENT TO “TELAPREVIR EXPERIENCE FROM TURKEY”

Pages

  0-0

Abstract

 Dear EditorWe have read with great interest the article entitled “Telaprevir experience from TURKEY” by Komur et al. recently.First of all, we have applauded the efforts of the authors and the editors of journal for putting forward this controversial and wondered topic for us. Currently, the HEPATITIS C treatment is in a very dynamic situation, due to newly introduced potent drugs. Therefore, the most popular guidelines (AASLD, EASL and APASL) have constantly updated the treatment recommendations, based on the new evidences from the effects and side-effects of these drugs. Thereby, every comment on novel potent drugs is very important for the clinicians, who have insufficient experience with them. We firstly want to discuss the content of the article and present to our experience that selected patients are more difficult to treat as a group, with different and strange side-effects.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    AKAR, TARIK, MALKOC, DILEK, & AYDEMIR, SELIM. (2015). COMMENT TO “TELAPREVIR EXPERIENCE FROM TURKEY”. HEPATITIS MONTHLY, 15(11), 0-0. SID. https://sid.ir/paper/306915/en

    Vancouver: Copy

    AKAR TARIK, MALKOC DILEK, AYDEMIR SELIM. COMMENT TO “TELAPREVIR EXPERIENCE FROM TURKEY”. HEPATITIS MONTHLY[Internet]. 2015;15(11):0-0. Available from: https://sid.ir/paper/306915/en

    IEEE: Copy

    TARIK AKAR, DILEK MALKOC, and SELIM AYDEMIR, “COMMENT TO “TELAPREVIR EXPERIENCE FROM TURKEY”,” HEPATITIS MONTHLY, vol. 15, no. 11, pp. 0–0, 2015, [Online]. Available: https://sid.ir/paper/306915/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button